Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Munich 2018 Banner MR

ESMO COLLOQUIUM - Hepatocellular carcinoma treatment: Now, next and beyond

This educational activity is provided by ESMO and supported by Eisai.
View the ESMO colloquium details

ESMO COLLOQUIUM - Systemic therapies in unresectable hepatocellular carcinoma (HCC): 1st and later lines

This educational activity is provided by ESMO and supported by IPSEN.
View the ESMO colloquium details

ESMO COLLOQUIUM - Immune check point inhibitors: Are we ready for combination?

This educational activity is provided by ESMO and supported by Celgene.
View the ESMO colloquium details

ESMO COLLOQUIUM - Acute Myeloid Leukemia – Focus on FLT3-ITD mutation

This educational activity is provided by ESMO and supported by Daiichi Sankyo.
View the ESMO colloquium details

ESMO COLLOQUIUM - Are biosimilars the key to access, in practice?

This educational activity is provided by ESMO and supported by Amgen, MSD, Pfizer and Sandoz.
View the ESMO colloquium details

*Resources are not available.

All ESMO 2018 Resources

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings